Unlocking new frontiers in clinical mass spectrometry
CLINICAL24
Clinical mass spectrometry offers highly precise, sensitive and multiplexed detection of biomarkers, metabolites and drugs directly from patient samples. This could mean earlier detection of diseases, better monitoring of treatment responses, personalized drug dosing, and more. The technology is increasingly being applied in areas like newborn screening, infectious disease identification, toxicology, endocrinology and cancer biomarker discovery. The technology solutions explored in this feature are for clinical research use only and not for clinical diagnostic purposes, unless expressly stated by the manufacturer.
The automated clinical mass spectrometry revolution
Mass spectrometry expert Professor Joe El-Khoury shares how automation is reshaping clinical diagnostics to boost throughput, reduce manual steps, and expand access to advanced testing. Learn how automated MS tools are overcoming traditional bottlenecks and driving a new era in lab efficiency.
Watch video
MSACL notions on the evolution and future of clinical mass spectrometry
Hear from four experts in the clinical space as they share their views on clinical mass spectrometry and how it is transforming laboratory practice. Gain insights into its evolution, key challenges, and the role of automation in improving diagnostic accuracy and efficiency.
Read article
Revolutionizing vitamin D assessment with the power of LC-MS/MS
Mass spectrometry, particularly LC-MS/MS, offers superior sensitivity, specificity, and accuracy over traditional immunoassays in assessing vitamin D levels. In this exclusive interview, Dr. Benjamin Lilienfeld, Lifecycle Leader Serum Work Area Systems, Senior Vice President, Roche tells us more.
Read interview
EVOQ DART-TQ+ featuring ClinMass now and ClinDART just ahead
In this application note, discover the EVOQ® DART-TQ+, the only instrument that can switch fast and easily between conventional LC-MS and fully integrated chromatography-free DART-MS technologies. Download this resource to learn more.
Download resource
Bruker set to bring chromatography-free diagnostics to the masses
Jeff Zonderman, Vice President of Bruker Applied Mass Spectrometry, unveils major strides in clinical diagnostics with the acquisition of RECIPE, a leading provider of mass spectrometry diagnostic kits for small molecule analysis.
Watch interview
